Merck Recalls Supply Of Cholesterol Drug Liptruzet

Law360, Washington (January 14, 2014, 7:35 PM EST) -- Merck & Co. said Tuesday it is immediately recalling all lots of its cholesterol drug Liptruzet in the U.S. and Puerto Rico due to packaging defects that could affect the drug's efficacy.

According to the company, the outer foil packaging surrounding the Liptruzet tablets may allow air and moisture to come into contact with the drug, which could affect its efficacy and physical characteristics. Merck maintained that it had not received any adverse event reports or quality complaints that sparked the voluntary recall decision.

“The likelihood...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.